A Phase I Dose-Finding Trial of Recombinant Interleukin-21 and Rituximab in Relapsed and Refractory Low Grade B-cell Lymphoproliferative Disorders

✍ Scribed by Timmerman, J. M.; Byrd, J. C.; Andorsky, D. J.; Yamada, R. E.; Kramer, J.; Muthusamy, N.; Hunder, N.; Pagel, J. M.

• Book ID: 115497328
• Publisher: American Association for Cancer Research
• Year: 2012
• Tongue: English
• Weight: 371 KB
• Volume: 18
• Category: Article
• ISSN: 1078-0432
• DOI: 10.1158/1078-0432.ccr-12-0456